Zealand Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Zealand Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About ZEAL

Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. 

CEO
Adam Sinding Steensberg, MD, MBA
CEOAdam Sinding Steensberg, MD, MBA
Employees
481
Employees481
Headquarters
Soborg, Zealand
HeadquartersSoborg, Zealand
Founded
1997
Founded1997
Employees
481
Employees481

ZEAL Key Statistics

Market cap
1.25B
Market cap1.25B
Price-Earnings ratio
-4.51
Price-Earnings ratio-4.51
Dividend yield
Dividend yield
Average volume
1.70K
Average volume1.70K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$32.94
52 Week high$32.94
52 Week low
$9.93
52 Week low$9.93

ZEAL News

The Motley Fool 9h
A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.

The GLP weight-loss space has become increasingly competitive as new players have entered what many believe is a game-changing new market that’s still in the ea...

A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.
MarketWatch 16h
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial

A late-stage trial of a weight-loss drug found about a fifth of users discontinuing the treatment due to tolerability. Zealand Pharma lost a fifth of its marke...

Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
Investing.com 17h
Zealand Pharma crashes 26% as obesity drug’s side effects, dropouts disappoint - Investing.com

...

Zealand Pharma crashes 26% as obesity drug’s side effects, dropouts disappoint - Investing.com

More ZEAL News

TipRanks 1d
Zealand Pharma announces Boehringer’s phase III results of survodutide

Zealand Pharma (ZLDPF) announced that Boehringer Ingelheim has reported positive results from two global Phase III trials of its glucagon/GLP-1 dual agonist sur...

TipRanks 4d
Zealand Pharma price target raised to DKK 300 from DKK 275 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Zealand Pharma (ZLDPF) to DKK 300 from DKK 275 and keeps a Hold rating on the shares. Unlock trusted, data-back...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.